Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04466527 · ClinicalTrials.gov registry record · NA
Laser Treatment of Moderate to Severe Acne Vulgaris
A NA study of Acne Vulgaris, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT04466527 is a NA study of Acne Vulgaris that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 22 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04466527, a NA study of Acne Vulgaris, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, we are enrolling subjects with moderate to severe acne vulgaris and investigating the use of a commercially available laser in treating acne.
Conditions Studied
Interventions
- DEVICE Laser Intervention
Study Locations (1)
Massachusetts
- MGH Clinical Unit for Research Trials & Outcomes in Skin - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-05-20 |
| Est. Completion | 2025-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04466527
The ClinicalTrials.gov registry entry for NCT04466527 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (92% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Laser Intervention is the first listed.
NCT04466527 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04466527 about?
NCT04466527 is a clinical study titled "Laser Treatment of Moderate to Severe Acne Vulgaris". In this study, we are enrolling subjects with moderate to severe acne vulgaris and investigating the use of a commercially available laser in treating acne.
What is the current status of trial NCT04466527?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2021-05-20. Estimated completion is 2025-11.
What conditions does trial NCT04466527 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT04466527?
The interventions under investigation include: Laser Intervention (DEVICE).
Who is sponsoring clinical trial NCT04466527?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04466527 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Post Market Device Study for the Treatment of Acne
ACTIVE NOT RECRUITING · NA
-
A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin
COMPLETED · NA
-
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone
COMPLETED · NA
-
Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris
COMPLETED · NA
-
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
COMPLETED · NA
-
A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.